Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:0874)
19.20
-0.23 (-1.18%)
At close: Feb 13, 2026
HKG:0874 Market Cap
HKG:0874 has a market cap or net worth of 44.17 billion as of February 13, 2026. Its market cap has decreased by -0.09% in one year.
Market Cap
44.17B
Enterprise Value
43.99B
Revenue
84.74B
Ranking
n/a
PE Ratio
13.53
Stock Price
19.20
Market Cap Chart
Since February 6, 2001, HKG:0874's market cap has increased from 3.51B to 44.17B, an increase of 1,157.22%. That is a compound annual growth rate of 10.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 44.17B | 0.01% |
| Dec 31, 2025 | 44.17B | -5.06% |
| Dec 31, 2024 | 46.52B | -5.21% |
| Dec 29, 2023 | 49.08B | -6.35% |
| Dec 30, 2022 | 52.40B | -18.06% |
| Dec 31, 2021 | 63.96B | 20.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinopharm Group | 65.91B |
| 160 Health International | 21.16B |
| ETHK Labs | 2.10B |
| Sipai Health Technology | 1.61B |
| China Health Group | 790.09M |
| Charmacy Pharmaceutical | 626.40M |
| ClouDr Group | 568.23M |
| Sinco Pharmaceuticals Holdings | 376.08M |